Dose reduction in EP (Xres 3 vs Xres 4)

Dose reduction in EP (Xres 3 vs Xres 4) - Dose reduction in EP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37806

Enrollment

136

Registered

2012-04-06

Start date

2012-04-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation ventricular tachycardia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients with heart rhythm disturbances undergoing an interventional treatment for their heart rhythm disturbance • Patients to be treated with ablation for atrial fibrillation (paroxysmal, persistent or permanent), atypical atrial flutter or patients to be treated with ablation for ischemic or non-ischemic ventricular tachycardia

Exclusion criteria

Exclusion criteria: • patients under 18 years of age

Design outcomes

Primary

Measure	Time frame
•Stochastic effect of X-ray dose expressed in Dose Area Product (DAP) •Deterministic effect of X-ray dose expressed in Air Kerma (AK)	—

Secondary

Measure	Time frame
• Staff dose measured by DoseAware and Electronic Personal Dosimeter (EPD) • Physician professional judgment on procedural success (yes/no) • Physician professional judgment on adequacy of images for performing the EP procedure (yes/no) • Procedure duration (measured as time between time of first puncture to time of catheter removal) • Fluoro and exposure times • Fluoro flavors	—

Countries

Netherlands

Outcome results